ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,260.09
1.07%
Dow Jones
42,392.27
-0.36%
Gold vs US Dollar
2,658.945
1.32%
Brent Oil
75.855
2.71%
Bitcoin
96,869.16
2.63%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Revance Therapeutics Inc (RVNC) Share Price

RVNC Revance Therapeutics Inc

3.06
0.02 (0.66%)
After Hours
Last Updated: 22:00:15
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Revance Therapeutics Inc NASDAQ:RVNC NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.02 0.66 3.06 3.04 3.07 3.08 3.03 3.04 3,293,437 22:00:15   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 234.04M -323.99M -3.0885 -0.99 318.9M
 Type  Size  Price  Time  Units 
 9 2 3.04 22:44:36 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RVNC News
02/01/202521:45EDGAR2Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/01/202521:36EDGAR2Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
19/12/202414:00EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
12/12/202413:01EDGAR2Form SC 14D9 - Solicitation, recommendation statements
12/12/202413:00PRNUSCrown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share
12/12/202412:15EDGAR2Form SC TO-T - Tender offer statement by Third Party
12/12/202411:01EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for RVNC

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Revance Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads